CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
113 hedge funds and large institutions have $227M invested in Cymabay Therapeutics in 2021 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 26 increasing their positions, 41 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
39% less call options, than puts
Call options by funds: $2.1M | Put options by funds: $3.45M
59% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 29
Holders
113
Holding in Top 10
3
Calls
$2.1M
Puts
$3.45M
Top Buyers
| 1 | +$2.38M | |
| 2 | +$2.18M | |
| 3 | +$2.02M | |
| 4 |
Morgan Stanley
New York
|
+$1.7M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$753K |
Top Sellers
| 1 | -$5.36M | |
| 2 | -$3.3M | |
| 3 | -$2.3M | |
| 4 |
Two Sigma Advisers
New York
|
-$2.05M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.6M |